New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.
Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”
Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.
China private equity could deliver some strong vintages relative to other markets given falling valuations, a deepening pool of management talent, and a historical emphasis on driving returns through growth rather than leverage, industry participants...
Japanese enterprise billing and invoicing software provider LayerX has raised JPY 2bn (USD 13.2m) from Hong Kong’s Keyrock Capital Management, lifting its Series A round to around USD 67.5m
Japanese private equity firm Integral Corporation has sold most of its remaining position in Skymark Airlines, the budget air carrier it took public in December last year.
India’s Honasa Consumer, the private equity-backed parent of mother-and-baby brand Mamaearth, raised about USD 204m in a domestic IPO, facilitating several partial exits.
Norwest Venture Partners has invested INR 4.5bn (USD 54m) in Indian hospital operator Regency Healthcare, facilitating an exit for HealthQuad, which generated a 3x return.
Teachers’ Venture Growth (TVG), the late-stage growth investment arm of Ontario Teachers' Pension Plan (OTPP), has invested USD 80m in Indian logistics start-up Xpressbees.
India’s Alta Capital, a real assets and early-stage property tech investor, has committed USD 200m to an expansion effort by Cappella Educore, a chain of K-12 schools and student housing.
The Riverside Company has notched a sizeable exit with the sale of Australia’s Energy Exemplar as the GP expands its local team and launches its fourth Australia fund
Indian private equity firm True North took advantage of regulatory reforms to convert Fincare SFB from a non-bank into a bank. A merger with listed peer AU SFB will finally deliver an exit
Private equity investors are leaning into energy transition with new funds, strategies, and attitudes about risk as more emerging categories go mainstream. Regulation remains the perennial spoiler
An Abu Dhabi-headquartered sovereign investor Mubadala has a USD 276bn portfolio with interests across six continents. Luca Molinari, who leads Asia direct investments, outlines the regional strategy
Jean Eric Salata, head of BPEA EQT and chair of EQT Asia, on the benefits of diversification, why Asia’s limited reliance on leverage could lead to better relative performance, and being creative with liquidity
Pools of institutional – and less institutional – capital in Asia are deepening, but it remains a multi-speed market with some investors just beginning their alternatives journey and others achieving maturity
Large LPs concentrating their GP relationships is comfortably the biggest fundraising challenge facing private equity firms in Asia Pacific, according to a survey featured in the latest edition of Dechert’s global private equity report.
India’s Euler Motors, a logistics-focused electric three-wheeler maker, has lifted its Series C round to about USD 83m with a USD 14m tranche featuring cleantech investor Green Frontier Capital.
Australian turnaround investor Anchorage Capital Partners has closed its fourth fund with AUD 505m (USD 327m) in commitments.
Ascendent Capital Partners has joined the battle for Hollysys Automation, a US-listed Chinese provider of industrial automation and rail transportation solutions, by submitting a bid that values the business at USD 1.6bn.
01.AI, a large language model (LLM) launched less than eight months ago by Chinese venture capital firm Sinovation Ventures, has achieved a USD 1bn-plus valuation, according to Kai-Fu Lee, the firm’s founder.
Guoquan Food, a Chinese hotpot ingredients supplier that now positions itself as a one-stop home meal solutions brand, is trading at a 8.8% premium to its IPO price following a HKD 411.4m (USD 52.5m) Hong Kong offering.
Australia’s Five V Capital has confirmed an investment of undisclosed size in Cyclotek, a radioactive drug maker positioning itself as part of an industry transition toward personalized medicine.